This non-exclusive agreement is said to be a key component of a larger strategic initiative by Guava Technologies. The initiative is a direct response to a voiced need for sophisticated cell analysis technology to support higher throughput research in a compact, automated, and easy-to-use platform.
As part of the agreement, Guava Technologies has established straightforward and worry-free processes for purchase, installation, and service of the complete, integrated solution.
The new cell analysis system delivers both sample preparation and cell analysis technologies directly to the laboratory benchtop. It is compatible with a range of Guava turnkey assays in 96-well format, including the Guava ViaCount assay for cell counting and viability.
Lawrence Bruder, CEO of Guava Technologies, said: “With this agreement we can immediately deliver an automated walk-away solution for cell analysis to meet the ever-increasing need for higher throughput cell biology that many labs face in today’s environment of fast-paced, answer-focused, and efficiency-conscious research.”